Global burden of disease attributable to diabetes mellitus in Brazil;Carga global de doença devida e atribuível ao diabetes mellitus no Brasil

Cadernos de Saude Publica

Volumn 25, Issue 6, 2009, Pages 1234-1244

  de Oliveira, Andreia Ferreira ^a   Valente, Joaquim Gonçalves ^a   Leite, Iuri da Costa ^a   Schramm, Joyce Mendes de Andrade ^a   de Azevedo, Anne S Renteria ^b   Gadelha, Angela Maria Jourdan ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b NEW YORK CITY HEALTH AND HOSPITALS CORPORATION   (United States)

Author keywords

Cost of illness; Diabetes mellitus; Potential years of life lost

Indexed keywords

EID: 71749109443     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/s0102-311x2009000600006     Document Type: Article

References (53)

1. Sociedade Brasileira de Diabetes. Consenso Brasileiro sobre Diabetes 2002: diagnóstico e classifica-ção do diabetes melito e tratamento do diabetes melito tipo 2. Rio de Janeiro: Diagraphic Editora; 2003.
2. Organización Panamericana de la Salud. La diabetes en las Américas. Bol Epidemiol (Wash) 2001; 22:1-3.
3. Barceló A, Rajpathak S. Incidence and prevalence of diabetes mellitus in the Americas. Rev Panam Salud Pública 2001; 10:300-8.
4. World Health Organization. The World Health Report 2002: reducing risks, promoting healthy life. Geneva: World Health Organization; 2002.
5. Willett WC, Koplan JP, Nugent R, Dusenbury C, Puska P, Gaziano TA. Prevention of chronic disease by means of diet and lifestyle changes. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al., editors. Disease control priorities in developing countries. New York: World Bank/Oxford University Press; 2006. p. 833-50.
6. Rodgers A, Lawes CMM, Gaziano T, Vos T. The growing burden of risk from high blood pressure, cholesterol, and bodyweight. In: Jamison DT, Bre-man JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al., editors. Disease control priorities in developing countries. New York: World Bank/Ox-ford University Press; 2006. p. 851-68.
7. Santos AM. Diagnóstico do diabete melito, drogas utilizadas no tratamento e terapia combinada. In: Luna RL, Sabra A, organizadores. Medicina de fa-mília: saúde do adulto e do idoso. Rio de Janeiro: Editora Guanabara Koogan; 2006. p. 849-57.
8. Toscano CM. As campanhas nacionais para detecção das doenças crônicas não-transmissíveis: dia-betes e hipertensão arterial. Ciênc Saúde Coletiva 2004; 9:885-95.
9. Oliveira JEP, Monteiro JB, Araújo CGS. Diabetes melito tipo 2: terapêutica clínica prática. Rio de Ja-neiro: Medline; 2003.
10. Nayaran KM, Gregg EW, Fagot-Campagna A, Engelgau MM, Vinicor F. Diabetes: a common, growing, serious, costly and potentially preventable public health problem. Diabetes Res Clin Pract 2000; 50 Suppl 2:S77-84.
11. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21:1414-31.
12. Gruber W, Lander T, Leese B, Songer T, Williams R. The economics of diabetes and diabetes care. A report of the Diabetes Health Economics Study Group. Brussels: International Diabetes Federation; 1998.
13. Malerbi DA, Franco LJ. Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 yr. The Brazilian Cooperative Group on the Study of Diabetes Prevalence. Diabetes Care 1992; 5:1509-16.
14. Centers for Disease Control and Prevention. Diabetes-related amputations of lower extremities in the Medicare population: Minnesota, 1993-1995. MMWR Morb Mortal Wkly Rep 1998; 47:649-52.
15. Brand FN, Abbott RD, Kannel WB. Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study. Diabetes 1989; 38:504-9.
16. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 1998; 21:1138-45.
17. Haffner SM. Coronary heart disease in patients with diabetes. N Engl J Med 2000; 342:1040-2.
18. Hayden JM, Reaven PD. Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors. Curr Opin Lipidol 2000; 11:519-28.
19. Kanters SD, Banga JD, Stolk RP, Algra A. Incidence and determinants of mortality and cardiovascular events in diabetes mellitus: a meta-analysis. Vasc Med 1999; 4:67-75.
20. United States Renal Data System. Executive summary of United States Renal Data System, 1994-1999. http://www.usrds.org (accessed on 20/Oct/2007).
21. Johnson PC, Doll SC, Cromey DW. Pathogenesis of diabetic neuropathy. Ann Neurol 1986; 19:450-7.
22. Levin ME. Foot lesions in patients with diabetes mellitus. Endocrinol Metab Clin North Am 1996; 25:447-62.
23. World Health Organization. Diet, nutrition and the prevention of chronic diseases. Geneva: World Health Organization; 2003.
24. Murray CJL, Lopez AD. Global comparative assessments in the health sector. Geneva: World Health Organization; 1994.
25. Dasgupta P, Sem A, Marglin S. Guidelines for project evaluation. New York: United Nations; 1972.
26. Layard R, Glaister S. Cost-benefit analysis. Cambridge: Cambridge University Press; 1994.
27. Lind RC, Stiglitz JE, Wilson R, Dasgupta P, Stockfisch JA. Discounting for time and risk in energy policy. Baltimore: Johns Hopkins University Press; 1982.
28. Gold MR, Siegel JE, Weinstein MC, Russell LB. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
29. Organização Mundial da Saúde. Classificação estatística internacional de doenças e problemas relacionados à saúde, 10a revisão. v. 1. São Paulo: Edusp; 1997.
30. Leite IC, Beltrão KI, Rodrigues RN, Valente JG, Campos MR, Schramm JMA. Projeção da carga de doença no Brasil (1998-2013). In: Buss PM, Temporão JG, Carvalheiro JR, organizadores. Vacinas, soros e imunizações no Brasil. Rio de Janeiro: Editora Fiocruz; 2005. p. 51-65.
31. Murray CJL, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Harvard: Harvard School of Public Health; 1996.
32. Pomerleau J, McKee M, Lobstein T, Knai C. The burden of disease attributable to nutrition in Europe. Public Health Nutr 2003; 6:453-61.
33. Mathers C, Vos T, Stevenson C. The burden of disease and injury in Australia: summary report. Canberra: Australian Institute of Health and Welfare; 1999.
34. Melse JM, Essink-Bot ML, Kramers PG, Hoeymans N. A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group. Am J Public Health 2000; 90:1241-7.
35. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global burden of disease and risk factors. Washington DC: World Bank/New York: Oxford University Press; 2006.
36. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3:e442.
37. Melo MS, Lolio CA, Lucena MAF, Kirzner CF, Martins SM, Barros MNDS. Causas múltiplas de morte em diabéticos no município de Recife, 1987. Rev Saúde Pública 1991; 25:435-42.
38. Lessa I, Silva MRB, Cardeal CM. Mortalidade proporcional pelo diabetes mellitus como causa básica e associada de morte nos espaços sociais da cidade Salvador, Brasil. Rev Baiana Saúde Pública 1991; 18:75-84.
39. Andresen EM, Lee JA, Pecoraro RE, Koepsell TD, Hallstrom AP, Siscovick DS. Underreporting of diabetes on death certificates, King Country, Washington. Am J Public Health 1993; 83:1021-4.
40. Gatling W, Tufail S, Mullee MA, Westacott TA, Hill RD. Mortality rates in diabetic patients from a community-based population compared to local age/sex matched controls. Diabet Med 1997; 14:316-20.
41. Ochi JW, Melton LJ, Palumbo PJ, Chu CA. A population based study of diabetes mortality. Diabetes Care 1985; 8:224-9.
42. Boutayeb A, Boutayeb S. The burden of non-communicable diseases in developing countries. Int J Equity Health 2005; 4:1-8.
43. Gagliardino JJ, Olivera EM, Barragán HL, Hernández RE. Diabetes mellitus e hipertensión arterial: aspectos clínicos y epidemiológicos en la población de La Plata. Medicina (B. Aires) 1995; 55: 421-30.
44. Gagliardino JJ, Olivera E. The regions and their health care systems: Latin America. In: Gruber W, Lander T, Leese B, Songer T, Williams H, editors. Economics of diabetes and diabetes care. A report of the Diabetes Health Economics Study Group. Brussels: International Diabetes Federation/Ge-neva: World Health Organization; 1997. p. 51-9.
45. Assunção MCF, Santos IS, Valle NCJ. Blood glucose control in diabetes patients seen in primary health care centers. Rev Saúde Pública 2005, 39:183-90.
46. Lopez-Stewart G, Tambascia M, Rosas-Guzmán J, Etchegoyen F, Ortega-Carrión J, Artemenko S. Control of type 2 diabetes mellitus among general practitioners in private practice in nine countries of Latin America. Rev Panam Salud Pública 2007; 22:12-20.
47. Bennett JC, Plum F. Cecil: tratado de medicina interna. 20a Ed. Rio de Janeiro: Editora Guanabara Koogan; 1997.
48. Williams RH. Textbook of endocrinology. 5th Ed. Philadelphia: W. B. Saunders Co.; 1974.
49. Ulson ACB, Abujamra S. Análise de 400 pacientes diabéticos portadores de retinopatia. Arq Bras Oftalmol 1986; 49:9-12.
50. Bernardes CHA, Penteado JG, Martins MF, Rosa VA, Tinós MS. Pé diabético: análise de 105 casos. Arq Bras Endocrinol Metab 1993; 37:139-42.
51. Franco LJ, Milech A, Pimazoni Neto A, Braga CDC, Malerbi D, Campos GP, et al. Estudo multicêntrico sobre a prevalência do diabetes mellitus no Brasil. Inf Epidemiol SUS 1992; 1:47-73.
52. Almeida AAL, Bonfante HLM, Moreira RO, Arbex AK, Souza GS, Maciel LG, et al. Perfil epidemiológico do diabetes mellitus auto-referido em uma zona urbana de Juiz de Fora, Minas Gerais. Arq Bras Endocrinol Metab 1999; 43:199-204.
53. Muggeo M, Verlato G, Bonora E. The Verona diabetes study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality. Diabetologia 1995; 38:318-25.